Site map
An overview of the available content on this site. Keep the pointer still over an item for a few seconds to get its description.
- Celebrating the launch of the Oxford Centre for Early Cancer Detection
- Using AI to improve endoscopic detection of oesophageal cancer
- Investigating circulating extracellular vesicles for the early detection of oesophageal cancer
- 7 year collaboration with Janssen to detect blood cancers earlier
- Detecting multiple myeloma earlier
- TAPS – a new method for detecting DNA methylation
- Transatlantic collaboration to support earlier detection of pancreatic and oesophageal cancer
- Improving myeloma diagnosis using simple blood tests
- Funding success for liver cancer early detection
- Oxford success at the liquid biopsy sandpit
- Early detection sandpit: artificial intelligence in medical image analysis
- Early detection artificial intelligence and digital pathology sandpit
- Searching for a pancreatic cancer DNA signature
- Boost for ovarian cancer early detection research
- Identification of circulating genomic and metabolic biomarkers of bile duct cancer
- Investigating the risk of cancer in patients with sporadic common variable immunodeficiency disorders (CVID)
- Window of opportunity for early cancer detection
- Crowd-sourcing approach to improve endoscopic detection of cancer
- Insights into the cell of origin for ovarian cancer – steps towards early detection
- Improved reagentless detection assay for protein biomarkers
- £10 million for Oxford-led cancer epidemiology studies
- CRUK Early Detection Primer Award for sarcoma research
- Understanding the link between unexplained weight loss and cancer diagnosis
- Prof Xin Lu honoured by the Royal Society
- External validation of an artificial intelligence tool for predicting malignancy in patients with lung nodules
- 3D-printing synthetic tissues
- Urine-based test for accurately assessing fatty liver disease
- Oxford technology holds great promise for a multi-cancer blood test
- Oxford-developed DNA methylation technology forms the basis of new startup company
- Investigating prostate cancer risk factors using routine blood tests
- Affordable approaches to earlier cancer diagnosis
- Oxford University to lead a new national programme of AI research to improve lung cancer screening
- Oxford-based QResearch secures funding for accelerating oesophageal cancer diagnosis
- Home tests for colorectal cancer could prioritise patients for referral
- OxCODE funds three early detection projects
- Using machine-learning approaches to identify blood cancer types
- Prioritising patients with unexpected weight loss for cancer investigation
- Early diagnosis projects win NIHR Research Capability Funding
- IGF-1 is a risk factor for several types of cancer
- Professor Ellie Barnes comments on the 2020 Nobel Prize for Medicine
- Oxfordshire-based SCAN pathway wins BMJ award
- OxCODE Associate Director appointed as Professor
- Tumour evolution has implications for liquid biopsy
- OxCODE researchers at the Early Detection of Cancer Conference 2020
- Funding boost for OxPLoreD early detection study
- Roadmap for early detection
- CRUK Oxford Centre Symposium 2020
- $410 million buy out for Oxford cancer detection technology
- New estimates of breast cancer risks associated with HRT
- OxCODE researchers present at NCRI 2020
- In conversation with Xin Lu
- Using AI to improve the quality of endoscopy videos
- Bioengineering the human gut
- Collating clinical data for liver disease research
- The impact of COVID-19 on breast cancer diagnoses
- Studying prostate cancer risk in the UK Biobank
- Potential of DNA-based blood tests for detecting pancreatic cancer earlier
- Investigating the effects of co-morbidities on liver cancer risk
- Roadmap to the Future
- Assessing the impact of the COVID-19 pandemic on bowel cancer services
- Oxford paper is the British Journal of General Practice’s top publication of 2020
- Studying viral genetics to aid liver cancer early detection
- OxCODE researcher presents at CRUK Early Diagnosis series
- Oxford success at the early detection sandpit on pancreatic cancer
- Developing a system to simultaneously detect genetic and epigenetic information
- Early detection of sarcomas using liquid biopsy
- DeLIVER clinical research study underway
- Funding to improve childhood, teenage and young adult cancer detection
- New funding for early diagnosis research using platelets
- FDA clearance for Oxford spin-out’s early lung cancer diagnosis software
- CRUK Early Detection Primer Award for research into the clinical application of single cell genomics
- High testosterone levels in men linked to increased melanoma risk
- New clinical prediction tools for myeloma
- New method for cost-effective genome-wide DNA methylation analysis
- Ludwig-Oxford Symposium on Cancer Early Detection and Epigenetics – a recap
- Understanding mutation progression to detect ovarian cancer earlier
- Prostate cancer risk tool
- Professor David Hunter honoured by the Academy of Medical Sciences
- Funding success for Oxford’s early cancer detection researchers
- Artificial intelligence tool for streamlining pathology workflow
- AI endoscopy enables 3D surface measurements of pre-cancerous condition in oesophagus
- Clinical academic research partnership to improve myeloma early diagnosis
- Early diagnosis of lymphoma in children and young adults in sub-Saharan Africa
- Oxford University and partners win government funding to evaluate Paige Prostate Cancer Detection System
- New network Oxford Cancer launches
- Development of accurate long-read single-cell sequencing
- Oxford spin-out partners with Johnson & Johnson to improve lung cancer survival rates
- Oxford’s cancer-risk research featured in special edition of PLOS Medicine focussed on advances in early cancer detection
- OxCODE funds three early detection projects
- Oxford to assess revolutionary multi-cancer blood test in trial, for future implementation in the NHS
- Turing Fellowships for four OxCODE members
- Pancreatic cancer early detection funds awarded to OxCODE researchers
- Impact award for publication on ovarian cancer
- OxCODE researchers at the Early Detection of Cancer Conference 2021
- Identifying early clinical features of myeloma in primary care
- New symptoms identified that could help doctors diagnose pancreatic cancer
- World’s first cancer prevention trial to test diabetes drug in patients with high-risk genetic condition
- MP Anneliese Dodds tours Oxford cancer research
- New partnership for Oxford early cancer detection research spin-out
- Fewer cases of children’s cancer picked up during the COVID pandemic
- Datasets used to train AI to detect skin cancer are insufficient and lacking in pictures of darker skin
- Study sheds new light on the association between an infectious bacterium and gastric cancer in China
- New blood-based test is the first ever to simultaneously identify if a patient has cancer and if it has spread
- New study highlights importance of early diagnosis for ovarian cancer survival
- Oxford cancer symptoms paper is the second most read paper in the British Journal of General Practice in 2021
- Cancer Research UK to invest £11 million into cancer science in Oxford
- DeLIVER programme website launched
- Identifying protein biomarkers for pancreatic cancer
- Groundbreaking University of Oxford research could lead to early diagnosis of pancreatic cancer
- Funding to develop a new device for breast cancer detection
- TAPS for cancer detection
- Comparing models to predict liver cancer in individuals with high-risk conditions
- First major UK prospective study for liver cancer underway
- Adiposity in early life, but not adulthood, may protect against breast cancer
- Blood tests provide no additional information to FIT alone when prioritising patients for colorectal cancer referral
- Understanding AI-based lung nodule risk prediction
- A new opportunity for myeloma early diagnosis
- Oxford spin-out Optellum attains CE marking for its early lung cancer diagnosis AI technology
- Automated assessment of pathology image quality
- Funding to study stomach cancer development
- Predicting early recurrence of pancreatic cancer
- Greater adiposity linked to increased risk of fatal prostate cancer
- Early detection innovation award for Oxford researchers
- National clinical study launched to test new technologies for detecting liver cancer
- OxCODE funding scheme awards 2022
- Largest study to date confirms role of two hormones in aggressive prostate cancer risk
- Time-varying nature of clinical risk factors for pancreatic cancer may aid earlier diagnosis
- First DeLIVER study day
- Oxford research contributes to new guidelines on faecal immunochemical testing (FIT) in patients with signs or symptoms of suspected colorectal cancer
- Comparing polygenic risk scores for risk prediction in individuals
- Measured weight loss associates with an increased risk of a cancer diagnosis
- First patient diagnosed earlier using liquid biopsy technology as part of the AI-REAL programme in sub-Saharan Africa
- CRUK funding to investigate the molecular drivers of stomach cancer
- OxCODE travel awards 2022
- Funding to research metformin’s ability to delay or prevent cancers driven by the mutated TP53 gene
- Unique clinical imaging dataset released for artificial intelligence research to accelerate diagnosis of prostate cancer
- Cancer at Oxford
- Oxford Centre for Early Cancer Detection Symposium 2022 – a recap
- Oxford spinout Optellum secures $14m funding to advance pioneering AI-powered lung cancer diagnosis technology
- Funding boost for Oxford’s early cancer detection research in the NIHR Oxford BRC
- OxCODE researchers at the Early Detection of Cancer Conference 2022
- Pancreatic cancer could be diagnosed up to three years earlier
- Assessing a combined approach for risk-stratified population screening for colorectal cancer
- Dr Brian Nicholson reacts to news that GPs in England will have direct access to book cancer tests for their patients
- Public talk: Using blood tests to detect cancer
- Research confirms important differences in colorectal cancer patients with a history of Inflammatory Bowel Disease
- Major funding for Oxford will help find new cancer treatments
- Dr Jan Bornschein receives an MRC Clinical Academic Research Partnership (CARP) Award